FlowForma®, the leading provider of Process Automation tools for Microsoft Office 365®, has announced that Nipro...
QIAGEN N.V. recently announced that the Japanese Pharmaceuticals and Medical Device Agency (PMDA) has approved the thera...
The Polyplastics Group has announced the development of the DURACON(R) polyoxymethylene (POM) PM series for drug contact...
Eisai Co., Ltd. has been listed in the 2019 Global 100 Most Sustainable Corporations in the World (Global 100), a global...
The bone matrix contains various proteins, namely, collagen and other non-collagenous proteins. Osteoblasts are responsi...
Thyas has signed a licensing agreement with iPS Academia Japan, Inc. (iPS-AJ), a technology licensing organization of in...
Johnson & Johnson has announced the completion of the acquisition of Ci:z Holdings Co., Ltd. for a total purchase pr...
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that the U.S. Fo...
Daiichi Sankyo Company, Limited, Mitsubishi UFJ Capital Co., Ltd. and Tokyo Institute of Technology have announced that ...
Amgen and UCB announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorizat...
Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Minist...
NapaJen Pharma, Inc., a biotherapeutics company leveraging its proprietary immune cell-targeted oligonucleotide delivery...
Takeda Pharmaceutical Company Limited (“Takeda”) announced the completion of its acquisition of Shire plc (&...
FUJIFILM Corporation announced plans to invest approximately JPY 10 billion (approximately $90 million U.S. dollars) in ...
Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Sol...
Otsuka Pharmaceutical Co., Ltd. announces that its U.S. holding company subsidiary Otsuka America, Inc, and Click Therap...
Takeda Pharmaceutical has announced new research collaborations in immuno-oncology (I-O), an area of key strategic...
Researchers from Osaka University in Japan have discovered a way to convert human pluripotent stem cells into various ce...
